ProQR Therapeutics N.V. (PRQR) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 9 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for PRQR is $3.63, representing a +82.4% upside from the current price of $1.99. Price targets range from a low of $2.00 to a high of $5.00.
